API Supplies Products
Product | Therapeutic category | DMF |
---|---|---|
Aminocaprioc acid | Clotting promoter | DMF Ready |
Chlorzoxazone | Muscle relaxant | USDMF |
Canagliflozin (Amorphous) | Antidiabetic | USDMF |
Canagliflozin Hemihydrate | Antidiabetic | USDMF |
Chlorpromazine Hydrochloride | Antipsychotic | USDMF |
Dapsone | Anti-Bacterial / Anti Acne | USDMF |
Doxercalciferol | Hyperparathyroidism | USDMF |
Droxidopa | Neurogenic orthostatic hypotension | USDMF |
Eslicarbazepine acetate | Anticonvulsant | USDMF |
Emtricitabine | Antiretroviral | USDMF |
Efavirenz | Antiretroviral | USDMF |
Gabapentin Enacarbil | Analgesic | USDMF |
Mycophenolate Mofetil | Immunosuppressive agent | DMF |
Nimodipine | Anti-hypertensive | USDMF |
Nitazoxanide | Ant parasitic / Antiviral drug | USDMF |
Oseltamivir Phosphate | Antiviral (Influenza) drug | USDMF |
Oxcarbazepine | Anticonvulsant | USDMF |
Pimavanserin tartrate | Typical antipsychotic | USDMF |
Pregabalin | Muscle Relaxant | USDMF/ CEP/ KDMF |
Ranolazine | Anti Anginal | USDMF/ ASMF |
Sitagliptin Hydrochloride | Antidiabetic | USDMF / ASMF |
Sitagliptin Phosphate (mono) | Antidiabetic | USDMF / CEP |
Tenofovir Disproxil Fumarate | Anti HIV / AIDS | USDMF |
Trientine Hydrochloride | Wilson's disease | USDMF |
Tolvaptan | Hyponatremia | USDMF |
Terazosin | Antihypertensive | USDMF |
Valacyclovir HCl monohydrate | Antiviral | Filed (US) |
New Products (For Regulatory market)
Product | Therapeutic category | DMF |
---|---|---|
Carboprost Tromethamine | Prostaglandin | DMF Q2 |
Eltrombopag Olamine | Thrombopoietin-receptor agonist | DMF Q2 |
Levocetirizine | Antihistamine | USDMF Q2 |
Nitrofurantoin Macrocrystals | Antibiotic for UT Infections | USDMF Q2 |
Prazosin Hydrochloride | Anti-hypertensive | USDMF Q2 |
Ropinirole Hydrochloride | Anti-Parkinson’s | USDMF Q2 |
Fluvoxamine maleate | SSRI | Validation to be planned |
Suggamdex Sodium | Neuromuscular | USDMF Q2 |
Spironolactone | Anti-mineralocorticoid | Under Development |
Verapamil HCL | Calcium-channel blocker | Under Development |
Ziprasidone Mesylate Trihydrate | Anti-Schizophrenia | USDMF Q2 |
Oncology Products (For Regulatory market)
Product | Therapeutic category | DMF |
---|---|---|
Bicalutamide | Anti-Cancer | To be filed |
Erlotinib (Form A) | Anti-Cancer | Under Development |
Bendamustine HCl | Anti-Cancer | Under Development |
Cyclophosphamide ( Monohydrate) | Anti-Cancer | Under Development |
Imatinib Mesylate (Beta Form) | Anti-Cancer | Under Development |
New Products (For ROW)
Product | Therapeutic category | DMF |
---|---|---|
Bimatoprost | IH | Available |
Brivaracetam | ICH | Available |
Cetirizine | USP | Available |
Chloprostenol Sodium | USP / IH | Available |
Dinoprostone | USP / IH | Available |
Doxazosin Mesylate | IH | Available |
Latanoprost | USP / IH | Available |
Misoprostol | USP | Available |
Oclacitinib Maleate | IH | Available (Veterinary API) |
Silodosin | IH | Available |
Trazodone | USP | Available |
Travoprost | USP | Available |
Tafluprost | IH | Available |
Vildagliptin | IH | Available |
Ziprasidone DiHCL | USP | Available |